FDA Withdraws Approval For 11 Abbreviated Drug Applications
February 20, 2026
February 20, 2026
WASHINGTON, Feb. 20 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration is withdrawing the approval of 11 abbreviated new drug applications (ANDAs) following requests from several pharmaceutical manufacturers. The companies notified the agency that these specific drug products are no longer being marketed and voluntarily asked for the withdrawals.
The affected products include various medications such as Lidocaine HCl, Oxycodone HCl, and Proprano . . .
The affected products include various medications such as Lidocaine HCl, Oxycodone HCl, and Proprano . . .